Torsade de pointes: the clinical considerations

被引:67
作者
Gowda, RM
Khan, IA
Wilbur, SL
Vasavada, BC
Sacchi, TJ
机构
[1] Creighton Univ, Cardiac Ctr, Sch Med, Div Cardiol, Omaha, NE 68131 USA
[2] Long Isl Coll Hosp, Div Cardiol, Brooklyn, NY 11201 USA
关键词
Torsade de pointes; Long QT syndrome; ventricular tachycardia; sudden cardiac death; sudden arrhythmia death syndrome;
D O I
10.1016/j.ijcard.2003.04.055
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Torsade de pointes is a form of polymorphic ventricular tachycardia occurring in a setting of prolonged QT interval on surface electrocardiogram. Congenital causes of prolonged QT interval occur in individuals with genetic mutations in genes that control expression of potassium and sodium channels and acquired causes are numerous, predominantly drugs causing prolonged QT interval by blockade of potassium channels. Among the drugs, antiarrhythmic agents most notably quinidine, sotalol, dofetilide and ibutilide have the potential to induce the fatal torsade de pointes. Many non-antiarrhythmic drugs can also cause torsade de pointes. Although it is important to distinguish between the congenital and the acquired forms of long QT syndrome as the later can often be reversed by correction of the underlying disorder or discontinuation of the offending drug, both forms are not mutually exclusive. Clinical considerations and management of torsade de pointes are described. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 55 条
[31]   FEMALE GENDER AS A RISK FACTOR FOR TORSADES-DE-POINTES ASSOCIATED WITH CARDIOVASCULAR DRUGS [J].
MAKKAR, RR ;
FROMM, BS ;
STEINMAN, RT ;
MEISSNER, MD ;
LEHMANN, MH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (21) :2590-2597
[32]   Percutaneous overdrive pacing in the out-of-hospital treatment of torsades de pointes [J].
Monrabà, R ;
Sala, C .
ANNALS OF EMERGENCY MEDICINE, 1999, 33 (03) :356-357
[33]   POLYMORPHOUS VENTRICULAR-TACHYCARDIA - CLINICAL CHARACTERIZATION, THERAPY, AND THE QT INTERVAL [J].
NGUYEN, PT ;
SCHEINMAN, MM ;
SEGER, J .
CIRCULATION, 1986, 74 (02) :340-349
[34]   Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome [J].
Noda, T ;
Takaki, H ;
Kurita, T ;
Suyama, K ;
Nagaya, N ;
Taguchi, A ;
Aihara, N ;
Kamakura, S ;
Sunagawa, K ;
Nakamura, K ;
Ohe, T ;
Horie, M ;
Napolitano, C ;
Towbin, JA ;
Priori, SG ;
Shimizu, W .
EUROPEAN HEART JOURNAL, 2002, 23 (12) :975-983
[35]  
Ponti F.D., 2002, DRUG SAFETY, V25, P263, DOI DOI 10.2165/00002018-200225040-00004
[36]   Taking the "idio" out of "idiosyncratic": Predicting torsades de pointes [J].
Roden, DM .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (05) :1029-1034
[37]  
SALLE P, 1985, ANN CARDIOL ANGEIOL, V34, P381
[38]   LONG QT SYNDROME PATIENTS WITH MUTATIONS OF THE SCN5A AND HERG GENES HAVE DIFFERENTIAL RESPONSES TO NA+ CHANNEL BLOCKADE AND TO INCREASES IN HEART-RATE - IMPLICATIONS FOR GENE-SPECIFIC THERAPY [J].
SCHWARTZ, PJ ;
PRIORI, SG ;
LOCATI, EH ;
NAPOLITANO, C ;
CANTU, F ;
TOWBIN, JA ;
KEATING, MT ;
HAMMOUDE, H ;
BROWN, AM ;
CHEN, LSK ;
COLATSKY, TJ .
CIRCULATION, 1995, 92 (12) :3381-3386
[39]   QT PROLONGATION WITH TORSADE-DE-POINTES IN PHEOCHROMOCYTOMA [J].
SHIMIZU, K ;
MIURA, Y ;
MEGURO, Y ;
NOSHIRO, T ;
OHZEKI, T ;
KUSAKARI, T ;
AKAMA, H ;
WATANABE, T ;
HONMA, H ;
IMAI, Y ;
YOSHINAGA, K ;
TOTSUKA, H .
AMERICAN HEART JOURNAL, 1992, 124 (01) :235-239
[40]   Effects of a K+ channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome [J].
Shimizu, W ;
Antzelevitch, C .
CIRCULATION, 2000, 102 (06) :706-712